Andrew Danford represents life sciences and technology companies in intellectual property disputes. He has significant experience with biosimilar litigation under Biologics Price Competition and Innovation Act. He has also litigated numerous patent cases through trial and on appeal under the Hatch-Waxman Act, as well as on behalf of innovator pharmaceutical clients in declaratory judgment actions challenging patents held by a competitor. Mr. Danford has also litigated several patent disputes at the trial and appellate levels involving smartphones, microprocessors, telecommunications networks, internet technologies and video compression.
Mr. Danford’s practice encompasses all stages of litigation—from pre-suit investigations through discovery, summary judgment, trial and appeal. His recent trial experience includes several bench and jury trials in federal district courts in Delaware, California, Texas and Wisconsin. He has also appeared in numerous appeals before the US Court of Appeals for the Federal Circuit, as well as in several appeals before the US Supreme Court. In addition, Mr. Danford has experience representing clients in dozens of inter partes review proceedings before the Patent Trial and Appeal Board. He also has experience litigating patent disputes before the US International Trade Commission.
Updated Sep 2024
